PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. ("Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback